Welcome to Sanguinity

​Developing a drug for treatment in humans is risky
​and very expensive. 

​
Improve your odds of success with intelligent study design
​using biologically driven data.

Bringing a drug to market is expensive

The median cost of a clinical trial is ~$19 million, and the total cost to develop a single drug and bring it to market is 2-3 billion dollars. These numbers have a limiting effect on the numbers of new drugs that make it to market, and account for failure of many small to medium size pharmaceutical companies. ​

Most trials will fail

This is an unfortunate reality.  A blood test that would help predict which patients respond to a medication during the trials would improve the chances of trial success and would decrease the sizes and cost of trials.

Sanguinity can help

Every patient is different.  We use specialized algorithms derived from blood samples that account for inherited traits, environment and lifestyle.  We can work together to find the profile that fits your target population.
  

Design for success

We can determine the profile of patients with positive response or the best outcomes during Phase 1-2 trials.  This profile can be used during Phase 3 trials to engage in strategic enrollment and dramatically increase the likelihood of success and decrease the size and costs of a clinical trial. 

               The message is there. 
                               Can you afford not to listen?